Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. (2011)
Attributed to:
A novel system for perfusion and real-time analysis of single hESC-derived cardiomyocytes
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehr073
PubMed Identifier: 21367833
Publication URI: http://europepmc.org/abstract/MED/21367833
Type: Journal Article/Review
Volume: 32
Parent Publication: European heart journal
Issue: 8
ISSN: 0195-668X